Lincoln Pharmaceuticals Limited NSE Symbol:LINCOLN, BSE Security Code:531633 has declared its 1st(first) quarter un-audited Consolidated financial report from the month of April, 2020 to the month of June, 2020; for the fiscal year 2020-21.
Revenue Reported by Lincoln Pharmaceuticals Limited for First Quarter FY, 2020-21 | ||
Current Quarter (April, 2020 - June, 2020) | Previous Quarter (January, 2020 - March, 2020) | Corresponding Quarter (April, 2019 - June, 2019) |
105.59 | 82.65 | 98.11 |
Calculated Revenue of Lincoln Pharmaceuticals Limited for First Quarter FY, 2020-21 | |||
Current(June, 2020) VS Previous(March, 2020) | Current(June, 2020) VS Corresponding(June, 2019) | ||
Change | Change % | Change | Change % |
22.94 | 27.76%(Revenue Increase) | 7.48 | 7.62%(Revenue Increase) |
Revenue: Lincoln Pharmaceuticals Limited's financial report shows that the company's revenue increased by 27.76% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for revenue increase of Rs.22.94 crores, as the company posted revenue of Rs.105.59 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported revenue of Rs.82.65 crores.
The result also shows that the company's revenue increased by 7.62% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for revenue increase of Rs.7.48 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted revenue of Rs.98.11 crores.
Gross Margin(%) Reported by Lincoln Pharmaceuticals Limited for First Quarter FY, 2020-21 | ||
Current Quarter (April, 2020 - June, 2020) | Previous Quarter (January, 2020 - March, 2020) | Corresponding Quarter (April, 2019 - June, 2019) |
64.69 | 44.14 | 57.33 |
Calculated Gross Margin(%) of Lincoln Pharmaceuticals Limited for First Quarter FY, 2020-21 | |||
Current(June, 2020) VS Previous(March, 2020) | Current(June, 2020) VS Corresponding(June, 2019) | ||
Change | Change % | Change | Change % |
20.54 | 46.54%(GM Increase) | 7.36 | 12.83%(GM Increase) |
Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 46.54% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for 20.54% GM increase, as the company reported 64.69% GM; in compare to previous quarter(January, 2020 - March, 2020) when the company reported 44.14% GM.
The result also indicates, the company's GM increased by 12.83% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for 7.36% GM increase; in compare to corresponding quarter(April, 2019 - June, 2019) when the company reported 57.33% GM.
EBITDA Reported by Lincoln Pharmaceuticals Limited for First Quarter FY, 2020-21 | ||
Current Quarter (April, 2020 - June, 2020) | Previous Quarter (January, 2020 - March, 2020) | Corresponding Quarter (April, 2019 - June, 2019) |
23.96 | 12.80 | 20.35 |
Calculated EBITDA of Lincoln Pharmaceuticals Limited for First Quarter FY, 2020-21 | |||
Current(June, 2020) VS Previous(March, 2020) | Current(June, 2020) VS Corresponding(June, 2019) | ||
Change | Change % | Change | Change % |
11.16 | 87.19%(EBITDA Increase) | 3.61 | 17.74%(EBITDA Increase) |
EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 87.19% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EBITDA increase of Rs.11.16 crores, as the company posted EBITDA of Rs.23.96 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EBITDA of Rs.12.80 crores.
The result also shows that the company's EBITDA increased by 17.74% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EBITDA increase of Rs.3.61 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EBITDA of Rs.20.35 crores.
Profit and Loss Reported by Lincoln Pharmaceuticals Limited for First Quarter FY, 2020-21 | ||
Current Quarter (April, 2020 - June, 2020) | Previous Quarter (January, 2020 - March, 2020) | Corresponding Quarter (April, 2019 - June, 2019) |
15.62(Profit ) | 8.94(Profit ) | 12.68(Profit ) |
Calculated Profit and Loss of Lincoln Pharmaceuticals Limited for First Quarter FY, 2020-21 | |||
Current(June, 2020) VS Previous(March, 2020) | Current(June, 2020) VS Corresponding(June, 2019) | ||
Change | Change % | Change | Change % |
6.68 | 74.72%(Profit Increase) | 2.94 | 23.19%(Profit Increase) |
Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 74.72% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for profit increase of Rs.6.68 crores, as the company posted profit of Rs.15.62 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported profit of Rs.8.94 crores.
The result also shows that the company's profit increased by 23.19% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for profit increase of Rs.2.94 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted profit of Rs.12.68 crores.
EPS Reported by Lincoln Pharmaceuticals Limited for First Quarter FY, 2020-21 | ||
Current Quarter (April, 2020 - June, 2020) | Previous Quarter (January, 2020 - March, 2020) | Corresponding Quarter (April, 2019 - June, 2019) |
7.63 | 4.47 | 6.33 |
Calculated EPS of Lincoln Pharmaceuticals Limited for First Quarter FY, 2020-21 | |||
Current(June, 2020) VS Previous(March, 2020) | Current(June, 2020) VS Corresponding(June, 2019) | ||
Change | Change % | Change | Change % |
3.16 | 70.69%(EPS Increase) | 1.30 | 20.54%(EPS Increase) |
EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 70.69% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EPS increase of Rs.3.16, as the company posted EPS of Rs.7.63; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EPS of Rs.4.47.
The result also shows that the company's EPS increased by 20.54% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EPS increase of Rs.1.30; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EPS of Rs.6.33.
***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.
Comments